Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ siPORT™ NeoFX™ Transfection Agent with manual

Click to view available options
Quantity:
400 μL
1 mL
Product Type:
Transfection Reagent
Transfection Reagent with Manual
Description
Includes
One tube containing 0.4mL
- Versatile-works with a broad range of cell lines
- Reproducible-produces consistent results, lot-to-lot, plate-to-plate, and well-to-well
- Efficient-performs with high siRNA transfection efficiency, allowing use of low siRNA concentrations to minimize nonspecific effects
- Fast-reverse-transfects cells as they are plated, saving a day
- Reverse-Transfect Cells as They are Plated, Saving a Day
- Optimized for Lower siRNA Concentrations and High Reproducibility
- Compatible with a Broad Range of Cell Lines
Cell Culture, RNAi Transfection, Synthetic siRNA Transfection, Transfection
Order Info
Shipping Condition: Room Temperature

Specifications
Specifications
Classification | Animal Origin-Free |
Content And Storage | Store at 4°C. |
Cell Type | Stem Cells, Primary Cells, Mammalian |
Format | 6-well Plate, 12-well Plate, 24-well Plate, 48-well Plate, 96-well Plate, Flasks |
Sample Type | Synthetic siRNA |
Transfection Technique | Lipid-based Transfection |
For Use With (Application) | Transfection |
High-throughput Compatibility | High-throughput Compatible |
Product Line | Ambion™, siPORT™ |
Product Type | Transfection Reagent |
Show More |
Safety and Handling
WARNING: Cancer and Reproductive Harm - www.P65Warnings.ca.gov
For Research Use Only. Not for use in diagnostic procedures.
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction